| scholarly article | Q13442814 |
| P50 | author | David J Nikolic-Paterson | Q42467005 |
| P2093 | author name string | Atkins RC | |
| Tesch GH | |||
| Chow FY | |||
| Ozols E | |||
| Rollin BJ | |||
| P2860 | cites work | Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury | Q44692955 |
| Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis | Q45170289 | ||
| Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice | Q46460973 | ||
| Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. | Q51554738 | ||
| The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis | Q70225378 | ||
| The role of macrophages in diabetic glomerulosclerosis | Q70704470 | ||
| A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens | Q72412411 | ||
| Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats | Q73829192 | ||
| Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats | Q73929137 | ||
| Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats | Q78197780 | ||
| Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages | Q78560006 | ||
| NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy | Q80389149 | ||
| Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis | Q33834360 | ||
| Chemokines as regulators of T cell differentiation. | Q34139602 | ||
| Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. | Q35083615 | ||
| Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice | Q36375621 | ||
| Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice | Q36400287 | ||
| Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. | Q40684652 | ||
| Advanced glycosylation end products induce NF-kappaB dependent iNOS expression in RAW 264.7 cells | Q40702746 | ||
| Damaging effects of advanced glycation end-products in the murine macrophage cell line J774A.1. | Q40719520 | ||
| Regulation of nitric oxide production by murine peritoneal macrophages treated in vitro with chemokine monocyte chemoattractant protein 1. | Q40765518 | ||
| Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load | Q43675650 | ||
| Chronic diabetic nephropathy: role of inducible nitric oxide synthase | Q43856028 | ||
| In vitro activation of murine peritoneal macrophages by monocyte chemoattractant protein-1: upregulation of CD11b, production of proinflammatory cytokines, and the signal transduction pathway | Q44024701 | ||
| Interleukin-1beta stimulates human renal fibroblast proliferation and matrix protein production by means of a transforming growth factor-beta-dependent mechanism | Q44218097 | ||
| Mycophenolate mofetil prevents the development of glomerular injury in experimental diabetes | Q44242781 | ||
| Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy | Q44265195 | ||
| ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1. | Q44526996 | ||
| Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). | Q44599751 | ||
| Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy | Q44690145 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 73-80 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice | |
| P478 | volume | 69 |
| Q42512729 | 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells |
| Q46350486 | A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis |
| Q39697103 | A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy |
| Q51598828 | A recombinant TGF-β1 vaccine ameliorates diabetic nephropathy in OLETF rats. |
| Q90307901 | ALPK1 regulates streptozotocin-induced nephropathy through CCL2 and CCL5 expressions |
| Q35982758 | Abatacept Treatment Does Not Preserve Renal Function in the Streptozocin-Induced Model of Diabetic Nephropathy |
| Q37708046 | Abnormalities in signaling pathways in diabetic nephropathy. |
| Q36352141 | Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy |
| Q42641988 | Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice |
| Q39280135 | Advanced glycation endproducts stimulate renal epithelial cells to release chemokines that recruit macrophages, leading to renal fibrosis |
| Q36109288 | Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice |
| Q50522405 | An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes. |
| Q38868613 | Angiotensin II-induced hypertensive renal inflammation is mediated through HMGB1-TLR4 signaling in rat tubulo-epithelial cells |
| Q38118549 | Animal models of chronic kidney disease: useful but not perfect |
| Q38802833 | Anti-Diabetic Agent Sodium Tungstate Induces the Secretion of Pro- and Anti-Inflammatory Cytokines by Human Kidney Cells |
| Q47733423 | Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice |
| Q57702074 | Antiproteinuric Effect of Chemokine C-C Motif Ligand 2 Inhibition in Subjects with Acute Proliferative Lupus Nephritis |
| Q36666878 | Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics |
| Q34072566 | Astragalus membranaceus inhibits peritoneal fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in rats submitted to peritoneal dialysis |
| Q54651740 | Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response |
| Q26799505 | Biomarkers of Renal Disease and Progression in Patients with Diabetes |
| Q45232179 | Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice |
| Q43239328 | Bradykinin and high glucose promote renal tubular inflammation. |
| Q33620560 | C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria |
| Q33816616 | CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice |
| Q38593433 | CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease |
| Q42796833 | Calcium oxalate crystal deposition in metabolic syndrome model rat kidneys |
| Q36677752 | Can we target tubular damage to prevent renal function decline in diabetes? |
| Q42754556 | Cathepsin S-Dependent Protease-Activated Receptor-2 Activation: A New Mechanism of Endothelial Dysfunction |
| Q40791151 | Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase |
| Q37456159 | Chemokine profile in the sera and urine of patients with schistosomal glomerulopathy |
| Q50900167 | Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trial. |
| Q51246335 | Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy. |
| Q38495475 | Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. |
| Q60912377 | Coreopsis tinctoria Nutt ameliorates high glucose-induced renal fibrosis and inflammation via the TGF-β1/SMADS/AMPK/NF-κB pathways |
| Q43174450 | Critical role for osteopontin in diabetic nephropathy |
| Q38315999 | Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications |
| Q41854992 | Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. |
| Q44632321 | Cytokines in chronic kidney disease: potential link of MCP-1 and dyslipidemia in glomerular diseases |
| Q35944830 | Deletion of Rac1GTPase in the Myeloid Lineage Protects against Inflammation-Mediated Kidney Injury in Mice |
| Q61512392 | Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes |
| Q37597721 | Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury |
| Q43721013 | Diabetic kidney disease. |
| Q48025850 | Do propofol and isoflurane protect the kidney against ischemia/reperfusion injury during transient hyperglycemia? |
| Q38985548 | Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms |
| Q41854872 | Dual blockade of the homeostatic chemokine CXCL12 and the proinflammatory chemokine CCL2 has additive protective effects on diabetic kidney disease. |
| Q33704805 | Dual effect of chemokine CCL7/MCP-3 in the development of renal tubulointerstitial fibrosis. |
| Q37317440 | Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes |
| Q28080888 | Effects of Tumor Necrosis Factor-α on Podocyte Expression of Monocyte Chemoattractant Protein-1 and in Diabetic Nephropathy |
| Q37684896 | Emerging roles of hematopoietic cells in the pathobiology of diabetic complications |
| Q37244688 | Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes |
| Q28575856 | Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat |
| Q87791764 | Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria |
| Q61648712 | Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice |
| Q46615474 | Exendin-4 attenuates renal tubular injury by decreasing oxidative stress and inflammation in streptozotocin-induced diabetic mice |
| Q53192338 | Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats. |
| Q41951561 | Fcγ receptor deficiency attenuates diabetic nephropathy |
| Q34670737 | Fenofibrate attenuates tubulointerstitial fibrosis and inflammation through suppression of nuclear factor-κB and transforming growth factor-β1/Smad3 in diabetic nephropathy |
| Q34554570 | From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy |
| Q40139541 | Future strategies to prevent renal microvascular disease complications in diabetes. |
| Q33660629 | Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy |
| Q37000229 | Glomerular cell death and inflammation with high-protein diet and diabetes |
| Q36972397 | Growth hormone exacerbates diabetic renal damage in male but not female rats |
| Q35963122 | High glucose-induced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. |
| Q89578732 | IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target |
| Q49334493 | ISN Forefronts Symposium 2015: The Diverse Function of Macrophages in Renal Disease. |
| Q38936622 | Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets |
| Q36645971 | Implications of treatment that target protective mechanisms against diabetic nephropathy |
| Q35924532 | Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. |
| Q35821566 | Induction of hemeoxygenase-1 reduces renal oxidative stress and inflammation in diabetic spontaneously hypertensive rats |
| Q36659502 | Inflammation and diabetic nephropathy |
| Q26866480 | Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets |
| Q38042593 | Inflammation in diabetic nephropathy |
| Q38255902 | Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment. |
| Q36117573 | Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy |
| Q35133177 | Inflammatory cytokines in diabetic nephropathy. |
| Q37871339 | Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. |
| Q38225047 | Inflammatory processes in renal fibrosis. |
| Q38756737 | Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney disease. |
| Q36159004 | Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats |
| Q39496640 | Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice |
| Q64923813 | Interaction between galectin-3 and cystinosin uncovers a pathogenic role of inflammation in kidney involvement of cystinosis. |
| Q41789363 | Involvement of TAGE-RAGE System in the Pathogenesis of Diabetic Retinopathy |
| Q36153911 | Involvement of the NLRC4-Inflammasome in Diabetic Nephropathy |
| Q30453566 | Kidney-targeted transplantation of mesenchymal stem cells by ultrasound-targeted microbubble destruction promotes kidney repair in diabetic nephropathy rats |
| Q41200170 | Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy |
| Q51838560 | Kolaviron improved resistance to oxidative stress and inflammation in the blood (erythrocyte, serum, and plasma) of streptozotocin-induced diabetic rats. |
| Q41788971 | Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice. |
| Q43244384 | Lignin-derived lignophenols attenuate oxidative and inflammatory damage to the kidney in streptozotocin-induced diabetic rats |
| Q58051415 | Local Mineralocorticoid Receptor Activation and the Role of Rac1 in Obesity-Related Diabetic Kidney Disease |
| Q37686722 | Low protein diet inhibits uric acid synthesis and attenuates renal damage in streptozotocin-induced diabetic rats. |
| Q43084457 | Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury. |
| Q37221054 | MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease |
| Q38500312 | MCP-1/CCR2 system is involved in high glucose-induced fibronectin and type IV collagen expression in cultured mesangial cells |
| Q28817901 | Macrophage TGF-β1 and the Proapoptotic Extracellular Matrix Protein BIGH3 Induce Renal Cell Apoptosis in Prediabetic and Diabetic Conditions |
| Q41559116 | Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury |
| Q37440181 | Macrophages directly mediate diabetic renal injury |
| Q91259809 | Macrophages: versatile players in renal inflammation and fibrosis |
| Q39801451 | Mesangial cell-derived factors alter monocyte activation and function through inflammatory pathways: possible pathogenic role in diabetic nephropathy. |
| Q38213048 | Microinflammation in the pathogenesis of diabetic nephropathy |
| Q80558926 | Midkine is involved in tubulointerstitial inflammation associated with diabetic nephropathy |
| Q35754670 | Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells |
| Q36222092 | Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes |
| Q85225771 | Monocyte chemoattractant protein-1 (MCP-1) 2518G/A gene polymorphism in Turkish type 2 diabetes patients with nephropathy |
| Q38140956 | Monocyte chemoattractant protein-1 -2518G/A gene polymorphism and the risk of nephropathy in type 2 diabetes mellitus among Asians: a meta-analysis |
| Q58831541 | Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells |
| Q54567899 | Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. |
| Q30423561 | Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury |
| Q38063587 | Mononuclear phagocyte system in kidney disease and repair. |
| Q41506750 | Mori cortex prevents kidney damage through inhibiting expression of inflammatory factors in the glomerulus in streptozocin-induced diabetic rats |
| Q37861765 | Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developments |
| Q38265818 | Novel effective drugs for diabetic kidney disease? or not? |
| Q33570113 | Oxidative stress-induced JNK activation contributes to proinflammatory phenotype of aging diabetic mesangial cells |
| Q35673446 | Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy |
| Q47321983 | Pentosan polysulfate ameliorates apoptosis and inflammation by suppressing activation of the p38 MAPK pathway in high glucose‑treated HK‑2 cells |
| Q58699291 | Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice |
| Q46648044 | Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy |
| Q55496421 | Podocytes express IL-6 and lipocalin 2/ neutrophil gelatinase-associated lipocalin in lipopolysaccharide-induced acute glomerular injury. |
| Q53566631 | Pravastatin inhibits carboxymethyllysine-induced monocyte chemoattractant protein 1 expression in podocytes via prevention of signalling events. |
| Q43196259 | Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. |
| Q35763771 | Proregenerative Microenvironment Triggered by Donor Mesenchymal Stem Cells Preserves Renal Function and Structure in Mice with Severe Diabetes Mellitus. |
| Q35179985 | Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy |
| Q101226472 | Proteomic landscape of TGF-β1-induced fibrogenesis in renal fibroblasts |
| Q41669202 | Puerarin inhibits cardiac fibrosis via monocyte chemoattractant protein (MCP)-1 and the transforming growth factor-β1 (TGF-β1) pathway in myocardial infarction mice |
| Q36666799 | Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes |
| Q37780781 | Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy |
| Q34476839 | Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study |
| Q35033650 | Renal denervation prevents long-term sequelae of ischemic renal injury |
| Q37253944 | Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney |
| Q38054089 | Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications |
| Q37306789 | Reversal of Early Diabetic Nephropathy by Islet Transplantation under the Kidney Capsule in a Rat Model |
| Q60690483 | Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy |
| Q26849691 | Role of T cells in type 2 diabetic nephropathy |
| Q38188747 | Role of chemokines in proteinuric kidney disorders |
| Q88035415 | Role of the Immune System in Diabetic Kidney Disease |
| Q35730481 | Serum Levels of Progranulin Are Closely Associated with Microvascular Complication in Type 2 Diabetes. |
| Q35138098 | Serum amyloid A and inflammation in diabetic kidney disease and podocytes |
| Q37725539 | Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals |
| Q39735007 | Suppressors of cytokine signaling abrogate diabetic nephropathy |
| Q99241011 | Sweet dreams: therapeutic insights, targeting imaging and physiologic evidence linking sleep, melatonin and diabetic nephropathy |
| Q87462719 | Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients |
| Q42365354 | TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1 |
| Q33761954 | Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation |
| Q36998106 | Targeting c-fms kinase attenuates chronic aristolochic acid nephropathy in mice |
| Q26852726 | Targeting inflammation in diabetes: Newer therapeutic options |
| Q55079098 | Taxifolin attenuates diabetic nephropathy in streptozotocin-induced diabetic rats. |
| Q35827493 | The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy |
| Q45967786 | The JNK Signaling Pathway in Renal Fibrosis. |
| Q34050210 | The MCP-1/CCR2 axis in podocytes is involved in apoptosis induced by diabetic conditions |
| Q86949355 | The PPARβ/δ agonist GW501516 attenuates peritonitis in peritoneal fibrosis via inhibition of TAK1-NFκB pathway in rats |
| Q37828061 | The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress |
| Q38144642 | The effect of bariatric surgery on renal function and disease: a focus on outcomes and inflammation. |
| Q41042820 | The effects of anti-inflammatory and anti-angiogenic DNA vaccination on diabetic nephropathy in rats |
| Q48364814 | The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial-mesenchymal transition of peritoneal mesothelial cells. |
| Q37264349 | The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. |
| Q41308457 | The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes |
| Q53467733 | The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy. |
| Q34527184 | The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential |
| Q40153047 | The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice. |
| Q51552860 | The roles of Kruppel-like factor 6 and peroxisome proliferator-activated receptor-γ in the regulation of macrophage inflammatory protein-3α at early onset of diabetes |
| Q38296021 | Therapeutic oligonucleotides with polyethylene glycol modifications. |
| Q35079607 | Therapeutic targets for treating fibrotic kidney diseases |
| Q35720839 | Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy |
| Q46699745 | Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy |
| Q35996116 | Tripterygium Glycosides Tablet Ameliorates Renal Tubulointerstitial Fibrosis via the Toll-Like Receptor 4/Nuclear Factor Kappa B Signaling Pathway in High-Fat Diet Fed and Streptozotocin-Induced Diabetic Rats |
| Q34525152 | Urinary microRNA-10a and microRNA-30d serve as novel, sensitive and specific biomarkers for kidney injury |
| Q55312504 | Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease. |
| Q90067485 | hs-CRP Is Associated With Incident Diabetic Nephropathy: Findings From the Jackson Heart Study |
Search more.